SCOPOLAMINE MARKET ANALYSIS

Side effects associated with usage of scopolamine can hamper the market growth. Scopolamine, although effective in treating motion sickness and postoperative nausea and vomiting, often causes undesirable anticholinergic effects that discourage patients from opting for it. Common side effects of scopolamine include dry mouth, blurred vision, constipation, difficulty urinating, drowsiness, and confusion. In some cases, scopolamine also cause hallucinations and delirium. This makes its usage risky, especially in elderly patients who are more susceptible to anticholinergic toxicity. In 2020, according to a study published by British Medical Journal, analyzing drugs commonly implicated in cases of delirium, scopolamine patch ranked third among the culprit medications. The risks and side effects associated with scopolamine discourage its use, especially for long term treatment or prevention purposes.

Market Opportunities: Emerging markets in developing countries

Emerging markets in developing countries can offer opportunity for scopolamine market growth. Many developing nations across Latin America, Asia, and Africa are experiencing rapid economic growth and rising disposable incomes. As living standards improve in these regions, there is huge demand for advanced healthcare products. Scopolamine, which is commonly used for treating motion sickness and postoperative nausea/vomiting, has widespread applications that can benefit public health in developing nations. As more people gain access to vehicles, air travel, and modern medical care in emerging economies, there has been increase in incidence of conditions treatable by scopolamine. For instance, the number of road accidents resulting in nausea or vomiting is projected to grow considerably in parallel with motorization rates in developing countries over the coming decade. Expanding healthcare infrastructure and greater availability of effective drugs like scopolamine plays a key role in improving management of nausea/vomiting associated with these accidents. The volume of surgeries performed annually is increasing in developing countries. Better postoperative care using antiemetics such as scopolamine can help expedite recovery and reduce complications arising from nausea/vomiting.